- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/192 - Radicals derived from carboxylic acids from aromatic carboxylic acids
Patent holdings for IPC class C07D 295/192
Total number of patents in this class: 364
10-year publication summary
|
53
|
32
|
34
|
36
|
19
|
44
|
21
|
14
|
15
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3399 |
10 |
| Agios Pharmaceuticals, Inc | 216 |
10 |
| Imago Biosciences, Inc. | 38 |
8 |
| Akebia Therapeutics, Inc. | 113 |
7 |
| King Abdulaziz University | 508 |
7 |
| PTC Therapeutics, Inc. | 481 |
6 |
| AstraZeneca AB | 2917 |
5 |
| Dongguk University Industry-Academic Cooperation Foundation | 429 |
5 |
| The University of Liverpool | 304 |
5 |
| VALO Health, Inc. | 172 |
5 |
| Board of Regents, The University of Texas System | 5772 |
4 |
| The Trustees of Columbia University in the City of New York | 3566 |
4 |
| Mayo Foundation for Medical Education and Research | 3201 |
4 |
| Annji Pharmaceutical Co., Ltd. | 15 |
4 |
| Canopy Growth Corporation | 219 |
4 |
| Owen-barry Pharmaceuticals Inc. | 9 |
4 |
| Novartis AG | 10867 |
3 |
| Centre National de La Recherche Scientifique | 10414 |
3 |
| The Johns Hopkins University | 5659 |
3 |
| Catabasis Pharmaceuticals, Inc. | 36 |
3 |
| Other owners | 260 |